World-first stem-cell therapy shows promise for treating spina bifida in the womb
An in utero treatment using placenta-derived stem cells could treat infants with a neural-tube condition called spina bifida.…
New laser technique ensures integrity of mRNA therapeutics
Messenger RNA (mRNA) technology is transforming medicine by providing our cells with genetic instructions to produce proteins that…
Study sheds light on behavior of yeast cells in the gut
A new study sheds light on the behavior of yeast cells in the gut, paving the way for…
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…
RNA micelles enable targeted chemotherapy without immune toxicity
A new study in mice hints at the potential to use tiny particles made with RNA molecules to…
Eating beef as part of a healthy dietary pattern does not impact risk factors for type 2 diabetes
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D),…
New atlas of brain lysosomes sheds light on neurodegenerative disorders
Functioning brain cells need a functioning system for picking up the trash and sorting the recycling. But when…
Gene therapy targeting connexin 43 shows promise across inherited heart diseases
University of California San Diego-led team has discovered that restoring a key cardiac protein called connexin‑43 in a…
Targeted uterine mRNA treatment boosts fertility outcomes in mice
Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine – which designs nanotechnology-based platforms for…
Study shows DHPS enzyme controls macrophage maturation across multiple organs
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…
Web-based cytometry atlas reveals immune signatures across pancreatic cancer treatments
Oncologists have achieved some immune system responses in patients with pancreatic cancers using various combinations of vaccines and…
Preclinical study reveals potential new treatment for severe liver fibrosis
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis – a dangerous, disease-induced build-up of…